July 22, 2009 – Roche Diagnostics today introduced the Roche Cardiac 200, a comprehensive testing solution for rapid cardiac diagnostic needs in point-of-care testing environments.
The Roche Cardiac 200 is a lateral flow immunoassay testing system designed to provide quantitative cardiac marker test results on whole blood samples with a turnaround time of 10 to 19 minutes, to help meet best practice guidelines for emergency department settings.
Patients who present to the emergency department (ED) with symptoms of a cardiovascular event are typically tested for a series of "cardiac markers," or chemicals that the body releases as an indication of recent heart damage or potential cardiovascular problems. Often the ED physicians treating these patients cannot afford to wait for traditional testing methods, which can take longer than 60 minutes.
The Roche Cardiac 200 can process up to 36 tests per hour and offers a full cardiac marker menu that includes NT-proBNP, Troponin I (TnI), CKMB and Myoglobin. The instrument uses a unique internal corrected fluorescence measurement technology to deliver accuracy and reliability that are consistent with the performance expectations of laboratory systems as defined by the National Academy of Clinical Biochemistry. The company also said studies have shown that Roche Cardiac 200 diagnostic results for NT-proBNP and Troponin I are essentially equivalent to core lab results.
The Roche Cardiac 200 offers an easy-to-read touch screen and flexible modular configurations to enable labs to address specific workflow needs. It also uses a proprietary internal standard that eliminates the need for routine recalibration.
For more information: www.roche-diagnostics.us